Bioequivaelnce Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fed Conditions
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
To compare the single-dose oral bioavailability of clarithromycin 250 mg/5 mL powder for oral
suspension of Ranbaxy Laboratories with Biaxin 250 mg/5 mL granules for oral suspension in
healthy, adult, human, male subjects under fed conditions